Transcat (NASDAQ:TRNS) released its quarterly earnings results on Tuesday. The scientific and technical instruments company reported $0.33 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.28 by $0.05, MarketWatch Earnings reports. Transcat had a return on equity of 12.86% and a net margin of 4.66%. The business had revenue of $45.76 million during the quarter, compared to the consensus estimate of $45.50 million.
TRNS stock opened at $24.70 on Friday. The business’s 50-day moving average price is $26.85 and its 200-day moving average price is $29.94. The stock has a market cap of $201.78 million, a P/E ratio of 22.87, a PEG ratio of 2.90 and a beta of 0.76. The company has a quick ratio of 1.53, a current ratio of 2.26 and a debt-to-equity ratio of 0.39. Transcat has a twelve month low of $16.50 and a twelve month high of $34.18.
In other Transcat news, Director Carl E. Sassano sold 6,600 shares of the firm’s stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $30.18, for a total transaction of $199,188.00. Following the sale, the director now owns 62,884 shares in the company, valued at approximately $1,897,839.12. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 8.90% of the company’s stock.
Transcat, Inc provides calibration and laboratory instrument services in North America and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Featured Story: What are the benefits of momentum investing?
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.